Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy (Q33419693)

26 July 2017

title

Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy (English)

1 reference

26 July 2017

Hans J Baelde

2

0 references

author name string

Jamie S Chua

1

1 reference

26 July 2017

Malu Zandbergen

3

1 reference

26 July 2017

Suzanne Wilhelmus

4

1 reference

26 July 2017

Leendert A van Es

5

1 reference

26 July 2017

Johan W de Fijter

6

1 reference

26 July 2017

Jan A Bruijn

7

1 reference

26 July 2017

Ingeborg M Bajema

8

1 reference

26 July 2017

Danielle Cohen

9

1 reference

26 July 2017

publication date

8 January 2015

1 reference

Journal of the American Society of Nephrology

26 July 2017

published in

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

2239-2247

1 reference

Syndromes of thrombotic microangiopathy

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

The use of eculizumab in renal transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Pros and cons for C4d as a biomarker

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Eculizumab in severe Shiga-toxin-associated HUS

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Banff 07 classification of renal allograft pathology: updates and future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

The molecular biology of thrombotic microangiopathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

21 June 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Thrombotic Microangiopathies

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4552108

Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies

31 October 2018

1 reference

12 December 2020

Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab

1 reference

12 December 2020

Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Intestinal reperfusion injury is mediated by IgM and complement

1 reference

12 December 2020

Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney

1 reference

12 December 2020

Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2014050429

1 reference

26 July 2017

1 reference

26 July 2017

1 reference